Evidence map›Paper›PMID 38741884›Full record

ArticleCureus2024

From No Disease to Stage IV Colon Cancer in Four Months: A Case Report.

Antoine Jeri-Yabar, Liliana Vittini-Hernandez, Renzo Aller-Rojas, Francisco Arias-Reyes, Claudia Lozada Zingoni

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Antoine Jeri-YabarDepartment of Internal Medicine, Icahn School of Medicine at Mount Sinai Beth Israel, New York, USA.
Liliana Vittini-HernandezDepartment of Medicine, Icahn School of Medicine at Mount Sinai Beth Israel, New York, USA.
Renzo Aller-RojasDepartment of Internal Medicine, Clinica Anglo Americana, Lima, PER.
Francisco Arias-ReyesDepartment of Internal Medicine, Clinica Anglo Americana, Lima, PER.
Claudia Lozada ZingoniDepartment of Medical Oncology, Clinica Anglo Americana, Lima, PER.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer remains one of the most common cancers in the population. Meanwhile, steroids or other immunosuppressive drugs are usually given in rheumatological diseases as a treatment for flare-ups. Herein, we present the case of a 61-year-old female diagnosed with metastatic colorectal cancer merely four months following the commencement of glucocorticoid therapy for a recently diagnosed rheumatologic condition, despite a clear colorectal cancer screening colonoscopy conducted four months prior. The case report discusses the possible impact of corticosteroids on the fast disease progression of colorectal cancer and raises awareness regarding this potential risk.

Indexed as

colorectal canceroncologyscreeningstage iv colon cancersteroid

Identifiers

PMID38741884
PMCPMC11088957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.